HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplements And Personal Care Sales Boost Italian Online Pharmacy During COVID-19

Executive Summary

Sales of dietary supplements and personal care products helped Italy's online pharmacy channel grow by 25% in the twelve months to October 2021, IQVIA reports.

Trends for prevention and self-care during COVID-19 have boosted Italy’s online pharmacy channel, according to the latest data from IQVIA Consumer Health.

Sales of dietary supplements and personal care products helped the channel grow by 25% to €428m ($483m) in the twelve months to October 2021, IQVIA reports.

On an annual basis, last October’s e-pharmacy sales – which now include selected OTC medicines, thanks to a liberalisation of the channel by the Italian government – were 14% higher than the previous October.

 

Dietary supplements are the largest category of consumer healthcare products in the online pharmacy channel, and also grew in the 12 months.

Total unit sales of supplements in October 2021 also increased compared to the same month last year, by 12.3% to 1.64m units, IQVIA Consumer Health noted.

 

Personal care is another important category for online pharmacies in Italy, IQVIA Consumer Health pointed out.

Turnover of personal care products through Italian e-pharmacy for the entire 12 months ending in October 2021 totalled €143m.

In October, unit sales grew by 12% compared to October 2020, and 16% compared to September 2021.

 

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

RS152060

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel